Is it safe to go back to school? - Effects of SARS-CoV-2 viral load in children
The global COVID-19 pandemic has led to unprecedented levels of educational disruption through school closures. The resumption of in-person learning has proven to be controversial, as officials and communities weigh the risks of potential transmission of SARS-CoV-2 in schools against the benefits of in-person learning.
Antibodies can last for at least 6 months after the second dose of the COVID-19 mRNA vaccine
Members of the Moderna COVID-19 mRNA vaccine study group recently released a short correspondence in the New England Journal of Medicine, highlighting the persistent antibody response after the first six months of receiving the second dose of this vaccine.
Vaccines offer significant protection against many variants, including Delta
The clinical efficacy of several vaccines in protecting against symptomatic COVID-19, especially in light of the circulating variants, has been an emerging research topic.
Immunity in people who had COVID-19 appears to be long-lasting
Long-term data have emerged regarding the durability of antibody responses in people who had COVID-19. In a recent Nature article, a team lead by Rockefeller University researcher Dr. Michel Nussenzweig reported immunity results from 63 people recovering from severe COVID-19 (convalescent individuals) up to 12 months post-infection.
COVID-19 vaccines: six months and 2 billion doses later
On December 8th 2020 at 6:30 AM, the first COVID-19 vaccine was administered to a 90-year-old British woman in the United Kingdom.
Variants go Hellenic! WHO now using Greek letters as official names for COVID-19 variants
The World Health Organization (WHO) has recently announced a new naming system for coronavirus variants using Greek alphabet letters.
Pfizer and Moderna COVID-19 vaccines appear safe for teens
Pfizer-BioNTech and Moderna are reporting that their mRNA COVID-19 vaccines appear to be safe and efficacious in 12- to 16-year-olds, consistent with results reported for adults.
We are in this together: four strategies to right global vaccine inequity
In a Science commentary, journalists Jon Cohen and Kai Kupferschmidt highlight the ongoing health inequities in the global vaccine rollout while laying out a roadmap for moving forward.
Researchers say that vaccines can protect against some new variants, but two doses are more effective
Researchers from Public Health England looked at the vaccine effectiveness of the Pfizer-BioNTech and Oxford AstraZeneca vaccines against the COVID-19 variants originating in the UK and India.